vs
Side-by-side financial comparison of Barnes & Noble Education, Inc. (BNED) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $598.2M, roughly 1.9× Barnes & Noble Education, Inc.). Barnes & Noble Education, Inc. runs the higher net margin — 4.2% vs -127.8%, a 132.0% gap on every dollar of revenue. On growth, Barnes & Noble Education, Inc. posted the faster year-over-year revenue change (6.9% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $61.9M). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs 1.3%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BNED vs PRGO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.2M | $1.1B |
| Net Profit | $25.0M | $-1.4B |
| Gross Margin | 21.7% | 32.6% |
| Operating Margin | 6.8% | -116.0% |
| Net Margin | 4.2% | -127.8% |
| Revenue YoY | 6.9% | -2.5% |
| Net Profit YoY | -49.7% | -3093.9% |
| EPS (diluted) | $0.72 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $598.2M | $1.1B | ||
| Q3 25 | $274.2M | $1.0B | ||
| Q2 25 | $233.0M | $1.1B | ||
| Q1 25 | $419.7M | $1.0B | ||
| Q4 24 | $559.7M | $1.1B | ||
| Q3 24 | $250.9M | $1.1B | ||
| Q2 24 | $192.7M | $1.1B | ||
| Q1 24 | $415.4M | $1.1B |
| Q4 25 | $25.0M | $-1.4B | ||
| Q3 25 | $-18.3M | $7.5M | ||
| Q2 25 | $-23.0M | $-8.4M | ||
| Q1 25 | $17.9M | $-6.4M | ||
| Q4 24 | $43.2M | $-44.4M | ||
| Q3 24 | $-103.9M | $-21.0M | ||
| Q2 24 | $-41.9M | $-108.4M | ||
| Q1 24 | $-9.3M | $2.0M |
| Q4 25 | 21.7% | 32.6% | ||
| Q3 25 | 20.2% | 36.1% | ||
| Q2 25 | 30.3% | 34.4% | ||
| Q1 25 | 22.3% | 37.6% | ||
| Q4 24 | 23.0% | 33.9% | ||
| Q3 24 | 17.9% | 37.2% | ||
| Q2 24 | 28.7% | 37.0% | ||
| Q1 24 | 24.2% | 33.1% |
| Q4 25 | 6.8% | -116.0% | ||
| Q3 25 | -8.4% | 7.0% | ||
| Q2 25 | -4.9% | 4.3% | ||
| Q1 25 | 4.5% | 4.5% | ||
| Q4 24 | 8.4% | 10.0% | ||
| Q3 24 | -15.4% | 7.4% | ||
| Q2 24 | -16.3% | -2.5% | ||
| Q1 24 | 0.4% | -5.1% |
| Q4 25 | 4.2% | -127.8% | ||
| Q3 25 | -6.7% | 0.7% | ||
| Q2 25 | -9.9% | -0.8% | ||
| Q1 25 | 4.3% | -0.6% | ||
| Q4 24 | 7.7% | -3.9% | ||
| Q3 24 | -41.4% | -1.9% | ||
| Q2 24 | -21.7% | -10.2% | ||
| Q1 24 | -2.2% | 0.2% |
| Q4 25 | $0.72 | $-10.23 | ||
| Q3 25 | $-0.54 | $0.05 | ||
| Q2 25 | $2.97 | $-0.06 | ||
| Q1 25 | $0.59 | $-0.05 | ||
| Q4 24 | $1.63 | $-0.32 | ||
| Q3 24 | $-7.69 | $-0.15 | ||
| Q2 24 | $-15.68 | $-0.79 | ||
| Q1 24 | $-3.49 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.7M | — |
| Total DebtLower is stronger | $122.5M | — |
| Stockholders' EquityBook value | $283.2M | $2.9B |
| Total Assets | $1.1B | $8.5B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.7M | — | ||
| Q3 25 | $7.3M | $432.1M | ||
| Q2 25 | $9.1M | $454.2M | ||
| Q1 25 | $9.2M | $409.9M | ||
| Q4 24 | $11.6M | $558.8M | ||
| Q3 24 | $8.2M | $1.5B | ||
| Q2 24 | $10.5M | $542.8M | ||
| Q1 24 | $8.1M | $658.5M |
| Q4 25 | $122.5M | — | ||
| Q3 25 | $170.0M | — | ||
| Q2 25 | $103.1M | — | ||
| Q1 25 | $141.2M | — | ||
| Q4 24 | $177.6M | — | ||
| Q3 24 | $221.9M | — | ||
| Q2 24 | $196.3M | — | ||
| Q1 24 | $30.2M | — |
| Q4 25 | $283.2M | $2.9B | ||
| Q3 25 | $256.5M | $4.4B | ||
| Q2 25 | $272.2M | $4.5B | ||
| Q1 25 | $292.9M | $4.4B | ||
| Q4 24 | $211.4M | $4.3B | ||
| Q3 24 | $149.8M | $4.6B | ||
| Q2 24 | $80.4M | $4.5B | ||
| Q1 24 | $121.5M | $4.7B |
| Q4 25 | $1.1B | $8.5B | ||
| Q3 25 | $950.8M | $10.1B | ||
| Q2 25 | $790.3M | $10.1B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.0B | $9.6B | ||
| Q3 24 | $973.2M | $11.2B | ||
| Q2 24 | $909.9M | $10.4B | ||
| Q1 24 | $1.2B | $10.6B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 0.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.2M | $175.4M |
| Free Cash FlowOCF − Capex | $61.9M | $148.6M |
| FCF MarginFCF / Revenue | 10.4% | 13.4% |
| Capex IntensityCapex / Revenue | 0.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.6M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.2M | $175.4M | ||
| Q3 25 | $-67.6M | $51.7M | ||
| Q2 25 | $52.6M | $75.9M | ||
| Q1 25 | $-41.9M | $-64.5M | ||
| Q4 24 | $47.4M | $312.6M | ||
| Q3 24 | $-143.5M | $42.2M | ||
| Q2 24 | $81.7M | $9.5M | ||
| Q1 24 | $-35.8M | $-1.4M |
| Q4 25 | $61.9M | $148.6M | ||
| Q3 25 | $-71.3M | $29.8M | ||
| Q2 25 | $49.5M | $56.7M | ||
| Q1 25 | $-44.7M | $-90.0M | ||
| Q4 24 | $44.4M | $274.9M | ||
| Q3 24 | $-147.5M | $15.1M | ||
| Q2 24 | $79.1M | $-18.9M | ||
| Q1 24 | $-39.0M | $-26.5M |
| Q4 25 | 10.4% | 13.4% | ||
| Q3 25 | -26.0% | 2.9% | ||
| Q2 25 | 21.3% | 5.4% | ||
| Q1 25 | -10.7% | -8.6% | ||
| Q4 24 | 7.9% | 24.2% | ||
| Q3 24 | -58.8% | 1.4% | ||
| Q2 24 | 41.1% | -1.8% | ||
| Q1 24 | -9.4% | -2.4% |
| Q4 25 | 0.7% | 2.4% | ||
| Q3 25 | 1.4% | 2.1% | ||
| Q2 25 | 1.3% | 1.8% | ||
| Q1 25 | 0.7% | 2.4% | ||
| Q4 24 | 0.5% | 3.3% | ||
| Q3 24 | 1.6% | 2.5% | ||
| Q2 24 | 1.4% | 2.7% | ||
| Q1 24 | 0.8% | 2.3% |
| Q4 25 | 2.65× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.34× | — | ||
| Q4 24 | 1.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
